Tr1x, Inc.
Clinical trials sponsored by Tr1x, Inc., explained in plain language.
-
Could donor cells stop MS progression? early trial launches
Disease control Recruiting nowThis early-stage trial tests a cell therapy called TRX319 in 39 adults with progressive multiple sclerosis (MS). The goal is to see if it is safe and to find the best dose. Participants receive TRX319 infusions, sometimes after a chemotherapy drug called bendamustine, and are fol…
Phase: PHASE1, PHASE2 • Sponsor: Tr1X, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New cell therapy trial aims to tame stubborn Crohn's
Disease control Recruiting nowThis study tests an experimental cell therapy called TRX103 for people with moderate to severe Crohn's disease that hasn't improved with standard treatments. About 39 adults will receive TRX103 along with a low dose of a chemotherapy drug to prepare the body. The main goal is to …
Phase: PHASE1, PHASE2 • Sponsor: Tr1X, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC